Hedge Fund and Insider Trading News: Visium Asset Management, Soros Fund Management, Citadel, Casa Systems Inc (CASA), Andeavor (ANDV), and More

Insider Selling: Casa Systems (NASDAQ:CASA) Director Sells 4,717,520 Shares of Stock (WeekHerald.com)
Casa Systems Inc (NASDAQ:CASA) Director Peter Y. Chung sold 4,717,520 shares of Casa Systems stock in a transaction dated Monday, April 30th. The shares were sold at an average price of $25.00, for a total value of $117,938,000.00. The transaction was disclosed in a filing with the SEC.

Insider Selling: Andeavor (NYSE:ANDV) Director Sells 109,275 Shares of Stock (RegistrarJournal.com)
Andeavor (NYSE:ANDV) Director Jeff A. Stevens sold 109,275 shares of Andeavor stock in a transaction that occurred on Friday, April 27th. The shares were sold at an average price of $123.19, for a total transaction of $13,461,587.25. Following the completion of the transaction, the director now owns 1,196,578 shares of the company’s stock, valued at approximately $147,406,443.82. The transaction was disclosed in a legal filing with the Securities & Exchange Commission.

Insider Selling: Shake Shack (NYSE:SHAK) CEO Sells 20,000 Shares of Stock (WeekHerald.com)
Shake Shack Inc (NYSE:SHAK) CEO Randall J. Garutti sold 20,000 shares of the stock in a transaction that occurred on Thursday, April 26th. The stock was sold at an average price of $44.98, for a total value of $899,600.00. Following the completion of the transaction, the chief executive officer now owns 38,041 shares of the company’s stock, valued at $1,711,084.18. The sale was disclosed in a filing with the Securities & Exchange Commission.

Insider Buying: Hemispherx Biopharma (HEB) CEO Purchases 32,000 Shares of Stock (StockNewsTimes.com)
Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB) CEO Thomas K. Equels bought 32,000 shares of the company’s stock in a transaction that occurred on Friday, April 27th. The shares were purchased at an average cost of $0.32 per share, for a total transaction of $10,240.00. Following the acquisition, the chief executive officer now owns 524,919 shares of the company’s stock, valued at $167,974.08. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Insider Selling: NovoCure (NASDAQ:NVCR) CTO Sells 19,362 Shares of Stock (RegistrarJournal.com)
Novocure Ltd (NASDAQ:NVCR) CTO Yoram Palti sold 19,362 shares of the stock in a transaction dated Friday, April 20th. The stock was sold at an average price of $25.06, for a total transaction of $485,211.72. The sale was disclosed in a document filed with the SEC.